Telmisartan restricts Chikungunya virus infection in vitro and in vivo through the AT1/ PPAR-γ/MAPKs pathways
S. De, P. Mamidi, S. Ghosh, S. S. Keshry, C. Mahish, S. S. Pani, E. Laha, A. Ray, A. Datey, S. Chatterjee, S. Singh, T. Mukherjee, S. Khamaru, S. Chattopadhyay, B. B. Subudhi, S. Chattopadhyay
This study shows Telmisartan reduces Chikungunya virus infection in vitro and in vivo by modulating host pathways including AT1/PPAR-γ/MAPKs.
bioRxiv · Jul 30, 2021Microbiology